Resistance of influenza viruses to neuraminidase inhibitors--a review.
about
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsPerspectives on antiviral use during pandemic influenzaMutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cellsInfluenza: emergence and controlInhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomersPotent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutininRecent progress in structure-based anti-influenza drug designAnalysis of inhibitor binding in influenza virus neuraminidasePeramivir (BCX-1812, RWJ-270201): potential new therapy for influenzaZanamivir: from drug design to the clinicTreatment of influenza with neuraminidase inhibitors: virological implicationsRWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenzaCyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activitiesComparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza virusesNovel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping methodComparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passageNeuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.Drug resistance in influenza A virus: the epidemiology and management.Avian flu: isolation of drug-resistant H5N1 virus.Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus.In silico study on multidrug resistance conferred by I223R/H275Y double mutant neuraminidase.From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.Computational modeling and validation studies of 3-D structure of neuraminidase protein of H1N1 influenza A virus and subsequent in silico elucidation of piceid analogues as its potent inhibitors.Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.Only two residues are responsible for the dramatic difference in receptor binding between swine and new pandemic H1 hemagglutinin.Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birdsNeuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.Antiviral strategies for pandemic and seasonal influenzaThe 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium.In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir.In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.Progress in structure-based drug design against influenza A virus.Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitorsEffect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
P2860
Q22305941-FA61F615-0FD0-4541-831A-706AC047B18FQ24522384-E969CBE1-4D10-4614-97B1-0263C38D65CDQ24540532-0E6CCFBD-BEE3-4FF9-B732-365894228E18Q24559989-789BD1FE-AB3F-4047-8036-97273F7729E6Q24562911-2F861D98-D331-4731-A509-DBB9E451CDDFQ24675029-44880571-1F6F-4741-AC80-88D5BBCC24F2Q24680353-0853E880-3DB4-4BB3-B1BD-2507F0007AFDQ26863710-FEDBF3AA-1DC9-44C5-B502-5F848933EF26Q27630835-8109EE46-CB8E-4F12-B458-8160D78C7F29Q28201381-082C8B40-8EEE-4B9E-B2B5-C91C4A544EAEQ28344586-1B51A4D0-780E-4F13-BD0C-E0F4C4A758D5Q28344588-E0C47909-45A2-4013-8CC7-DE92A7506F86Q28344592-0F661772-15C4-45E3-A3EA-52973A48E51BQ28349496-672156DF-7FF2-4832-B110-15DF8BFB1D2BQ28364114-270E5A90-CD75-417D-9517-A5BAC068652BQ28472513-5C0D2937-D6AD-4766-84AF-EA4DDD9EBC61Q28478196-D5C43846-1C54-4186-A3E4-71CD1364F063Q28534776-3B14F3F5-6F14-417E-9173-9DA921BE358AQ30228322-22FC543F-D7F5-4351-AF5A-CD9CDB10E26AQ30234600-89CF21EA-4F3B-474C-A880-DE3DF1CFA97FQ30351638-13883DCF-3529-4C6F-8C9E-A9CBDDDB7A57Q30352689-9333EA84-BAE0-4615-AB42-51F80335B30AQ30353814-309C401B-319F-4460-87BB-35D0576908AEQ30363724-15E1511A-BAC2-4D7E-95E7-72B562C5E0F9Q30364619-B84019BA-4A09-4F11-9018-836871E01761Q30379716-5EA05291-D02C-4456-AF6C-01E645E4DFE6Q30386535-430C6FAC-7FB7-4FFF-BCAE-A40464755D5AQ30389890-A3C1B2DB-23D3-4FD8-A7B9-4F980D854B5DQ30397727-6B22AAA2-9A03-41C2-B747-722831175CF0Q30398804-6E57E9FF-D18D-4D66-925A-F3F302D6C499Q30404038-91F1BE81-B412-4812-A882-F30DC9ED8210Q30408116-D3E01560-E798-474E-A82B-F364A5E2613AQ30410229-D22A2D97-8244-4251-A459-227163F053C2Q30413673-821E1DEE-A796-4A5E-8D69-3809BDC6BC9BQ30413844-3FDF6D21-BA9B-4FF0-9C0B-62F8BC2F8F1DQ30416440-0579CBBD-5577-4785-ADA6-9757EFA585E1Q30417369-89240D83-89FC-4E96-93DA-BAEC3D71E02BQ30419391-BCC1B64D-70EE-4D35-9235-26949B4E3062Q30425126-DFEABA8C-E343-4914-957C-05F77535F5BBQ30438033-15944957-3D8A-497F-B068-766D24A0DA3E
P2860
Resistance of influenza viruses to neuraminidase inhibitors--a review.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Resistance of influenza viruses to neuraminidase inhibitors--a review.
@ast
Resistance of influenza viruses to neuraminidase inhibitors--a review.
@en
type
label
Resistance of influenza viruses to neuraminidase inhibitors--a review.
@ast
Resistance of influenza viruses to neuraminidase inhibitors--a review.
@en
prefLabel
Resistance of influenza viruses to neuraminidase inhibitors--a review.
@ast
Resistance of influenza viruses to neuraminidase inhibitors--a review.
@en
P1433
P1476
Resistance of influenza viruses to neuraminidase inhibitors--a review
@en
P2093
McKimm-Breschkin JL
P356
10.1016/S0166-3542(00)00103-0
P577
2000-07-01T00:00:00Z